Feline Nasal Lymphoma
Feline nasal lymphoma (FeNL) is a malignant neoplasm arising from lymphoid tissue within the nasal cavity and/or nasopharynx of cats, representing the most common primary nasal tumor in this species [8]. It is classified as an extranodal lymphoma, and while gastrointestinal lymphoma is the most prevalent form overall, nasal lymphoma constitutes a clinically significant subset of extranodal presentations [3]. The disease most commonly affects middle-aged to older cats and can be of T-cell or B-cell immunophenotype, with diffuse large B-cell lymphoma (DLBCL) being a recognized histological subtype [2]. Without treatment, progressive local invasion can lead to orbital extension, bone destruction, and serious complications; however, the tumor is generally considered radiosensitive, making radiation therapy the cornerstone of management [1].
- ·Chronic sneezing — often one of the earliest and most persistent owner-reported signs, reflecting mucosal irritation within the nasal cavity [7]
- ·Nasal discharge — may be unilateral or bilateral, ranging from serous to mucopurulent or bloody (epistaxis) [7]
- ·Epistaxis (nosebleeds) — mild to moderate hemorrhagic discharge, sometimes the initial sign prompting veterinary evaluation [7]
- ·Facial deformity or swelling — bony expansion or destruction of the nasal bridge and surrounding facial bones due to tumor growth [5]
- ·Eyelid swelling / exophthalmos — occurs when the tumor extends into the retrobulbar or orbital space [4, 6]
- ·Nasal obstruction / stertor — audible snoring or noisy breathing due to luminal occlusion by the mass [3]
- ·Anorexia and lethargy — systemic signs resulting from chronic disease, discomfort, or olfactory impairment [4]
- ·Nausea or inappetence — reported in cats with significant tumor burden or concurrent systemic involvement [4]
- ·Subcutaneous emphysema — a rare but reported complication when orbital blowout pathological fracture occurs secondary to aggressive tumor invasion [4]
- ·Weight loss — common in more advanced or chronic cases due to reduced food intake and systemic effects of neoplasia [3]
The precise etiology of feline nasal lymphoma remains incompletely understood. As with most feline lymphomas, it is thought to arise from clonal proliferation of malignant lymphocytes within the nasal mucosa-associated lymphoid tissue. The disease is classified as an extranodal lymphoma, meaning it originates in a site other than the lymph nodes, and the nasal cavity is the most common upper respiratory tract site [3].
Immunophenotypically, both T-cell and B-cell variants have been documented. High-grade T-cell lymphoma with aggressive local behavior has been reported, including cases causing orbital pathological fracture [4]. Diffuse large B-cell lymphoma (DLBCL) is a recognized B-cell subtype that has been specifically studied for predictors of early treatment failure [2]. The relative proportion of T- versus B-cell subtypes and their respective biological behaviors continue to be characterized in the literature [2].
Retroviral associations (FeLV, FIV) have been implicated in some feline lymphoma subtypes; however, specific associations with nasal lymphoma have not been definitively established, and many affected cats are retrovirus-negative [3]. Chronic local antigenic stimulation or inflammatory conditions within the nasal passages have been hypothesized as contributing factors, as seen with other mucosa-associated lymphoid tissue (MALT) lymphomas in veterinary and human medicine, but direct causal evidence in feline nasal lymphoma is limited.
Locally, the neoplasm infiltrates and destroys the turbinate bones, nasal septum, and adjacent structures including the cribriform plate, hard palate, orbit, and periorbital tissues. Orbital invasion can lead to blowout fractures of the orbital wall, resulting in rare complications such as subcutaneous emphysema and pneumomediastinum [4]. Systemic dissemination is possible, and early local or systemic failure has been reported in 17%–45% of cats following radiation therapy, underscoring the potential for both locoregional and distant progression [2].
Clinical Evaluation Diagnosis begins with a thorough history and physical examination, noting the duration and character of nasal signs, facial asymmetry, ocular involvement, and systemic condition. Retrobulbar extension should be assessed, as orbital neoplasia from nasal lymphoma is an important clinical presentation [6].
Advanced Imaging
- ·CT (Computed Tomography): The modality of choice for evaluating the extent of nasal and paranasal sinus involvement, bony destruction, orbital invasion, and cribriform plate integrity. CT allows precise tumor staging before treatment planning [8].
- ·MRI (Magnetic Resonance Imaging): Provides superior soft-tissue detail. A retrospective study characterizing MRI findings (including diffusion-weighted imaging, DWI) in cats with nasal lymphoma demonstrated that MRI can help differentiate lymphoma from adenocarcinoma, though overlap exists [8]. DWI in particular may offer additional tissue characterization.
Rhinoscopy and Biopsy Rhinoscopy allows direct visualization of nasal cavity lesions, and tissue biopsy for histopathology is essential for definitive diagnosis [7]. Histopathological confirmation, including immunohistochemistry to determine immunophenotype (T-cell vs. B-cell), is critical for diagnosis and for understanding prognosis [2].
Staging Full staging is recommended and includes:
- ·Thoracic radiographs or CT to evaluate for pulmonary involvement
- ·Abdominal ultrasound to assess for hepatic, splenic, or mesenteric lymph node involvement
- ·Bone marrow aspirate in selected cases to rule out systemic disease [3]
Laboratory Indicators While no laboratory finding is pathognomonic for nasal lymphoma, baseline bloodwork is essential to assess the patient's overall health and guide treatment tolerance:
- ·CBC: Anemia (low HCT/PCV) may be present in chronic disease; thrombocytopenia (low PLT) may occur in aggressive cases; leukocytosis or leukopenia can reflect systemic disease.
- ·Serum chemistry: Elevated globulins (GLOB) may be seen; hypoalbuminemia (low ALB) can indicate chronic illness or protein loss; elevations in ALT and BUN/CREA may reflect concurrent organ involvement or guide chemotherapy selection.
- ·Retroviral testing (FeLV/FIV): Recommended as part of a complete diagnostic workup, as retroviral status may influence prognosis and treatment decisions [3].
Radiation Therapy (Primary Standard of Care) Radiation therapy (RT) is considered the standard of care for localized feline nasal lymphoma [2]. The nasal tumor is generally radiosensitive, and RT can achieve significant tumor reduction and clinical remission.
- ·Stereotactic Body Radiation Therapy (SBRT): A modern, highly precise RT technique that delivers high doses over a small number of fractions. SBRT with or without adjuvant chemotherapy has been demonstrated to be an effective and well-tolerated treatment for localized nasal lymphoma in cats [1]. In a retrospective study of 32 cats treated with SBRT at Colorado State University between 2010 and 2020, the approach was found to be both safe and efficacious [1].
- ·Conventional or Definitive-Intent Fractionated RT: Historically used and also effective; the choice between SBRT and conventional RT depends on institutional capability and patient factors.
Chemotherapy
- ·Adjuvant multiagent chemotherapy (e.g., COP or CHOP-based protocols) may be combined with RT to address potential systemic micrometastatic disease and improve outcomes [5].
- ·Single-agent chlorambucil: In cats where RT is not feasible or desired, chlorambucil has been reported as a management option for nasopharyngeal lymphoma. A case report demonstrated long-term disease management with single-agent chlorambucil in a cat with nasopharyngeal lymphoma, representing an alternative for owners who decline aggressive treatment [7].
- ·Chemotherapy alone (without RT) may be considered in cases with systemic disease or when RT is not accessible.
Supportive Care
- ·Nutritional support (assisted feeding, appetite stimulants) to address anorexia and weight loss
- ·Management of secondary infections: broad-spectrum antibiotics for concurrent bacterial rhinitis
- ·Anti-nausea medications as needed
- ·Pain management and anti-inflammatory therapy where appropriate
- ·Monitoring and management of treatment side effects (mucositis, myelosuppression during chemotherapy)
Management of Complications Rare but serious complications such as orbital fracture with subcutaneous emphysema and pneumomediastinum require specific interventions including oxygen support, restricted activity, and possible surgical consultation [4].
Radiation-Induced Secondary Neoplasia A documented long-term concern is the development of secondary malignant neoplasms at the radiation field. A case of nasal adenocarcinoma suspected to be a secondary malignancy was reported in a cat previously treated with definitive RT and multiagent chemotherapy for nasal lymphoma 2.5 years prior [5]. This underscores the importance of long-term surveillance in surviving patients.
Feline nasal lymphoma generally carries a guarded to fair prognosis, and the disease is considered one of the more treatable extranodal lymphoma sites in cats when caught at a localized stage [3].
Key Survival Statistics:
- ·
SBRT outcomes: In the retrospective study of 32 cats treated with SBRT (with or without chemotherapy), SBRT was confirmed as an effective and well-tolerated approach, with meaningful survival times achieved [1]. This represents the most specific evidence for SBRT in this indication.
- ·
Early treatment failure: Early local or systemic tumor progression after RT (with or without chemotherapy) has been reported in 17%–45% of cats, highlighting a significant subset of patients who do not respond durably to initial treatment [2]. Investigations into pre-treatment biopsy characteristics as predictors of early failure are ongoing; however, no single histological parameter has yet been definitively identified as a reliable predictor [2].
- ·
Overall prognosis context: Many cats with extranodal lymphoma, including nasal lymphoma, present with Stage I or localized disease, which is generally associated with more favorable outcomes compared to multicentric or disseminated lymphoma [3].
- ·
Long-term complications: Survivors treated with definitive RT require long-term monitoring due to the risk of secondary malignant neoplasms arising within the radiation field, as evidenced by the development of nasal adenocarcinoma 2.5 years post-treatment in one reported case [5].
- ·
Single-agent chlorambucil: A long-term management outcome was documented in at least one cat with nasopharyngeal lymphoma maintained on chlorambucil alone, suggesting that durable disease control is possible even without RT in select cases [7].
- ·
Orbital involvement: Cats with retrobulbar or orbital extension of nasal lymphoma may face a more guarded prognosis due to the extent of local invasion and associated complications [4, 6].
Prognostic Factors: Immunophenotype (T-cell vs. B-cell), histological grade, degree of local invasion (cribriform plate/orbital involvement), and stage at presentation are considered relevant prognostic variables, though large prospective studies are lacking [3]. Pre-treatment biopsy characteristics are under active investigation as potential early-failure predictors specifically in DLBCL [2].
There are currently no known preventive measures or vaccines specific to feline nasal lymphoma. As with most feline lymphoid neoplasms, the etiology is multifactorial and not fully elucidated, making targeted prevention difficult.
General Recommendations:
- ·Retroviral screening and prevention: Since FeLV has been associated with certain feline lymphoma subtypes, ensuring cats are vaccinated against FeLV and tested for FeLV/FIV is a reasonable general oncology prevention strategy, though a direct causal link to nasal lymphoma specifically has not been established [3].
- ·Minimizing environmental carcinogen exposure: Avoiding secondhand tobacco smoke and other known environmental carcinogens may reduce overall cancer risk, though this has not been specifically studied for nasal lymphoma in cats.
- ·Regular veterinary examinations: Early detection through routine physical examination and prompt investigation of chronic nasal signs (persistent sneezing, nasal discharge, epistaxis) can lead to earlier diagnosis, which may allow treatment at a more localized and potentially more treatable stage [3].
- ·Long-term monitoring in treated cats: Given the documented risk of secondary malignancies following radiation therapy [5], cats treated with RT should receive regular follow-up examinations and imaging surveillance to detect recurrence or secondary neoplasia at the earliest possible opportunity.
METADATA
| Indicator | Abbr | Direction | Clinical Significance |
|---|---|---|---|
| 白蛋白 | ALB(2.5–4.5 g/dL) | Low ↓ | Hypoalbuminemia can reflect chronic illness or systemic involvement |
| 球蛋白 | GLOB(2.6–5.1 g/dL) | High ↑ | Hyperglobulinemia may be seen in some lymphoma patients |
| 血尿素氮 | BUN(14–36 mg/dL) | Either | Renal parameters assessed to guide chemotherapy dosing and rule out concurrent disease |
| 肌酐 | CREA(0.8–2.4 mg/dL) | Either | Renal function monitoring important before and during chemotherapy |
| 丙胺酸轉胺酶 | ALT(25–145 U/L) | High ↑ | Hepatic enzyme elevation may indicate hepatic involvement or drug toxicity during chemotherapy |
| 血容比 | HCT(24–45 %) | Low ↓ | Anemia may be present in chronic or advanced disease |
| 血小板 | PLT(200–500 10^3/μL) | Low ↓ | Thrombocytopenia may occur in aggressive or systemic disease |
Reference ranges sourced from MSD Veterinary Manual. Actual normal values vary by laboratory, age, and individual factors.
- [1]Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats.— Reczynska A., LaRue S., Boss M. et al., J Vet Intern Med, 2022PMID 35188694
- [2]Do Pre-Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?— Poirier V., Meier V., Turek M. et al., Vet Comp Oncol, 2025PMID 39631747
- [3]Extranodal lymphoma in the cat: prognostic factors and treatment options.— Moore A., J Feline Med Surg, 2013PMID 23603501
- [4]Subcutaneous emphysema and pneumomediastinum following orbital blowout pathological fracture in a cat with nasal lymphoma: a case report.— Oh Y., Hong H., Kim T. et al., BMC Vet Res, 2023PMID 37715215
- [5]Nasal adenocarcinoma as a suspected secondary malignant neoplasm in a cat previously treated for nasal lymphoma.— Callanan G., Curran K., Parachini-Winter C. et al., JFMS Open Rep, 2020PMID 32166040
- [6]Tumours involving the retrobulbar space in cats: 37 cases.— Jones B., Cotterill N., Drees R. et al., J Feline Med Surg, 2022PMID 35536054
- [7]Long-term management of a cat with nasopharyngeal lymphoma by chlorambucil.— Takahashi K., Baba T., Hirokawa M. et al., Open Vet J, 2021PMID 34307078
- [8]MRI findings, including diffusion-weighted imaging, in seven cats with nasal lymphoma and two cats with nasal adenocarcinoma.— Tanaka T., Ashida K., Iimori Y. et al., J Feline Med Surg, 2021PMID 32573314
References are matched to the content by AI and have not been human-verified to confirm each source supports the specific claim it accompanies. Open a source to check, and confirm with your veterinarian.